Erste Asset Management’s Cartesian Therapeutics RNAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.7M | Hold |
|
|||||
|
2025
Q1 | $3.43M | Buy |
|
|||||
|
2024
Q4 | $3.26M | Hold |
|
|||||
|
2024
Q3 | $2.8M | Buy |
|
|||||
|
2024
Q2 | $3.31M | Buy |
|
|||||
|
2024
Q1 | $2.09M | Buy |
|
|||||
|
2023
Q4 | $2.16M | Buy |
|
|||||
|
2023
Q3 | $2.69M | Buy |
|
|||||
|
2023
Q2 | $2.61M | Buy |
|
|||||
|
2023
Q1 | $2.88M | Hold |
|
|||||
|
2022
Q4 | $2.35M | Hold |
|
|||||
|
2022
Q3 | $3.4M | Sell |
|
|||||
|
2022
Q2 | $3.37M | Buy |
|
|||||
|
2022
Q1 | $2.5M | Buy |
|
|||||
|
2021
Q4 | $4.04M | Buy |
|